Study: Hundreds of rare disease drugs in testing

WASHINGTON (AP) — Good news for nearly 30 million Americans with a rare disease: Drugmakers are doing much more research on rare, often-deadly diseases with few or no treatment options.

They're running patient tests of more than 5,400 potential new medicines, many for multiple conditions. Nearly 1,800 research projects are for rare diseases. Hundreds more are for disorders with no new treatments in many years.

That's according to a study being released Thursday by the trade group Pharmaceutical Research and Manufacturers of America.

It found that thousands of those experimental drugs could be the first in a new medicine class with a unique target or effect. Nearly 600 use new technologies, from gene therapy to cloned antibodies, to precisely target the disease site. Others are for tiny subgroups of patients with genetic variations.

Federal officials' review of the fatal shooting of a 22-year-old black man by a white police officer as he carried an air rifle in an Ohio Wal-Mart remains unfinished as his relatives plan a rally and vigil to mark one year since his death. Get the story.

About 10TV

WBNS-TV’s on-line public inspection file can be found on the FCC website at 10tv.com/fcc. Individuals with disabilities may contact Becky Richey at pubfile@10tv.com or 614.460.3785 for assistance with access to the WBNS-TV public inspection files.